Chemoinformaics analysis of 3-EPIMASTICADIENOLALIC-ACID
| Molecular Weight | 368.338 | nRot | 5 |
| Heavy Atom Molecular Weight | 348.178 | nRig | 15 |
| Exact Molecular Weight | 368.111 | nRing | 2 |
| Solubility: LogS | -1.356 | nHRing | 0 |
| Solubility: LogP | 0.135 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 48.9439 |
| nHD | 5 | BPOL | 25.2721 |
| QED | 0.347 |
| Synth | 3.774 |
| Natural Product Likeliness | 2.093 |
| NR-PPAR-gamma | 0.763 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.406 |
| HIA | 0.929 |
| CACO-2 | -6.036 |
| MDCK | 0.000117669 |
| BBB | 0.701 |
| PPB | 0.767901 |
| VDSS | 0.298 |
| FU | 0.183774 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.09 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.67 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.168 |
| CYP3a4-inh | 0.02 |
| CYP3a4-sub | 0.041 |
| CL | 3.019 |
| T12 | 0.92 |
| hERG | 0.019 |
| Ames | 0.011 |
| ROA | 0.029 |
| SkinSen | 0.05 |
| Carcinogencity | 0.058 |
| EI | 0.016 |
| Respiratory | 0.029 |
| NR-Aromatase | 0.192 |
| Antiviral | Yes |
| Prediction | 0.69606 |